PTHS
Pelthos Therapeutics Inc.
21.30$
-0.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | 67.2% | 46.8% | 48.7% | 31.6% | 45.3% | |
| – | – | – | – | – | – | – | 32.8% | 53.2% | 51.3% | 68.4% | 54.7% | |
| – | – | – | – | – | – | – | 2.0% | 4.0% | 1.7% | 3.8% | 3.0% | |
| – | – | – | – | – | – | – | 162.5% | 137.3% | 121.6% | 118.3% | 130.8% | |
| – | – | – | – | – | – | – | 240.3% | 181.1% | 171.3% | 179.4% | 188.1% | |
| – | – | – | – | – | – | – | -207.4% | -127.8% | -120.0% | -111.0% | -133.4% | |
| – | – | – | – | – | – | – | 18.2% | 14.0% | 21.6% | 15.3% | 17.1% | |
| – | – | – | – | – | – | – | -225.5% | -304.5% | -93.9% | -150.1% | -182.3% | |
| – | – | – | – | – | – | – | -6.3% | -73.7% | – | – | – | |
| – | – | – | – | – | – | – | -219.3% | -230.7% | -93.9% | -150.1% | -165.2% | |
| – | – | – | – | – | – | – | -198.2% | -277.5% | -58.5% | -102.1% | -145.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.